Buradasınız

10 Yıllık Feokromasitoma Deneyimi ve Literatüre Bakış

A 10-Year Experience of Phemochromocytoma and an Overview to the Literature

Journal Name:

Publication Year:

Abstract (2. Language): 
The objective of this study was to analyze the data obtained from the patients having pheochromocytoma and to compare these data with the literature. In this study, we retrospectively evaluated the data of 16 cases admitted to our department between 1997 and 2007, and diagnosed as having phemochromocytoma. In ten years period, a total of 16 pheochromocytoma cases, 9 male and 7 female, aged 49.8±14.5 were included. Among 16 cases 14 had an anamnesis of hypertension for 2-8 years and 2 were newly diagnosed as hypertensive in their first admissions. 13 cases had hypertensive attacks and one case had chronic hypertension. A total of 11 patients, 6 of them during the hypertensive attacks, recieved antihipertensive drugs. 5 patients did not have any treatment. Tachycardia (68.7%), sweating (68.7%) and headache (62.5%) were accompanying hypertensive attacks. 14 patients (87.5%) underwent total mass excision surgery, but two patients could not be operated. Ten of the operated cases cured for hypertension, for 4 cases the antihipertensive treatment had to be repeated. Two patients with MEN-2A and one with malign pheochromocytoma died from progression of the disease or acute complications, the other 13 patients are still under follow-up. The patients who had prediagnosis of pheochromocytoma have to be evaluated with special laboratory examinations especially during attacks, and the ones who are diagnosed radiologically have to be treated surgically. With this treatment, cure can be achieved and the need for antihypertensive treatment may be not required, but these patients have to be followed for the other accompanying diseases and recurrences
Abstract (Original Language): 
Çalışmamızın Amacı feokromasitoma tanısı ile takip edilen hastalarda elde edilen bulguların incelenmesi ve literatür verileri ile karşılaştırılmasıdır. Araştırmamızda 1997–2007 yılları arasında bölümümüze başvuran hastalardan feokromasitoma tanısı almış 16 olguya ait veriler retrospektif olarak incelenmiştir. 10 yıllık dönemde yaşları 49,8±14,5 yıl olan 9 erkek, 7 kadın toplam 16 feokromasitoma olgusu tespit edildi. 16 olgunun 14’ünde 2–8 yıllık hipertansiyon (HT) öyküsü varken, 2 olguya ilk başvuru anında tanı konuldu. 13 olgu ataklar şeklinde, 1 olguda ise kronik HT mevcuttu. 6 hasta ataklar sırasında olmak üzere toplam 11 hasta antihipertansif tedavi alırken, 5 hasta ise herhangi bir tedavi almıyordu. Hipertansif ataklara en sık çarpıntı (%68,7), terleme (%68,7) ve baş ağrısı (%62,5) eşlik ediyordu. 14 hastaya (%87,5) total kitle eksizyonu gerçekleştirilirken, 2 hasta opere edilemedi. Opere olguların 10’unda (%73,3) HT kür ile sonuçlanırken, 4 (%26,6) olguya tekrar antihipertansif tedavi başlandı. MEN-2A’lı ve malign feokromasitomalı 2 hasta progresyon veya akut komplikasyon nedeniyle kaybedilirken, 1 hasta ise tümor nüksü sonrası hayatını kaybetmiş olup 13 olgunun poliklinik kontrolleri halen devam etmektedir. Feokromasitoma ön tanılı hastalarda özellikle ataklar sırasında spesifik laboratuvar incelemeleri yapılmalı ve görüntüleme yöntemleri ile tanı konulan hastalara cerrahi tedavi uygulanmalıdır. Bu tedavi ile kür sağlanabilir ve anti hipertansif tedavi ihtiyacı ortadan kalkabilirken, eşlik edebilen hastalıklar ve nüks açısından hastalar yakın takip edilmelidir.
11-16

REFERENCES

References: 

1- Lenders JW, Eisenhofer G, Mannelli M, Pacak K.
Phaeochromocytoma. Lancet. 2005 Aug 20-26;366(9486):665-
75
2- Karagiannis A, Mikhailidis DP, Athyros VG at all.
Pheochromocytoma: an update on genetics and management
Endocr Relat Cancer. 2007 Dec;14(4):935-56.
3- Pacak K, Eisenhofer G, Ahlman H, at all Pheochromocytoma:
recommendations for clinical practice from the First
International Symposium. October 2005 Nat Clin Pract
Endocrinol Metab. 2007 Feb;3(2):92-102.
4- Falchetti A, Marini F, Luzi E, at all. Multiple endocrine
neoplasms. Best Pract Res Clin Rheumatol. 2008
Mar;22(1):149-63
5- Widimský J Jr. Recent advances in the diagnosis and treatment
of pheochromocytoma. Kidney Blood Press Res.
2006;29(5):321-6. Epub 2006 Nov 21
6- Moreno AM, Castilla-Guerra L, Martínez-Torres MC at all.
Expression of neuropeptides and other neuroendocrine markers
in human phaeochromocytomas. Neuropeptides. 1999
Apr;33(2):159-63
7- Bravo EL. Pheochromocytoma: an approach to
antihypertensive management. Ann N Y Acad Sci. 2002
Sep;970:1-10
8- Eisenhofer G, Rivers G, Rosas AL at all. Adverse drug
reactions in patients with phaeochromocytoma: incidence,
prevention and management. Drug Saf. 2007;30(11):1031-62
9- Golshevsky JR, Karel K, Teale G. Phaeochromocytoma causing
acute pulmonary oedema during emergency caesarean section
Anaesth Intensive Care. 2007 Jun;35(3):423-7
10- Prys-Roberts C. Phaeochromocytoma--recent progress in its
management Br J Anaesth. 2000 Jul;85(1):44-57
11- Janssen OE, Mann K, Erbel R. Endocrine disorders and the
heart Internist (Berl). 2007 Mar;48(3):246-54
12- Cicala MV, Sartorato P, Mantero F. Incidentally discovered
masses in hypertensive patients. Best Pract Res Clin Endocrinol
Metab. 2006 Sep;20(3):451-66. Review.
13- Munk K, Jønler M. Acute cardiac failure in pheochromocytoma
Ugeskr Laeger. 2008 Jun 2;170(23):2039
14- Kearney T, Dang C Diabetic and endocrine emergencies.
Postgrad Med J. 2007 Feb;83(976):79-86
15- Eisenhofer G, Siegert G, Kotzerke J at all. Current progress and
future challenges in the biochemical diagnosis and treatment of
pheochromocytomas and paragangliomas Horm Metab Res.
2008 May;40(5):329-37
16- Rossi GP, Seccia TM, Pessina AC Clinical use of laboratory
tests for the identification of secondary forms of arterial
hypertension Crit Rev Clin Lab Sci. 2007;44(1):1-85
17- Tsunoda M Recent advances in methods for the analysis of
catecholamines and their metabolites. Anal Bioanal Chem.
2006 Oct;386(3):506-14. Epub 2006 Aug 10.
18- Dromain C, Baudin E Imaging strategy for staging and followup of endocrine tumors Bull Cancer. 2006 Dec 1;93(12):1183-9
19- Ilias I, Sahdev A, Reznek RH at all. The optimal imaging of
adrenal tumours: a comparison of different methods. Endocr
Relat Cancer. 2007 Sep;14(3):587-99
20- Aram V. Chobanian, MD George L. Bakris, MD Henry R.
Black, MD at all. The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure The JNC 7 Report JAMA.
published online May 14, 2003;
(doi:10.1001/jama.289.19.2560)
21- Mannelli M, Simi L, Gaglianò MS,Genetics and biology of
pheochromocytoma. Exp Clin Endocrinol Diabetes. 2007
Mar;115(3):160-5
22- Lee JA, Duh QY. Sporadic paraganglioma. World J Surg. 2008
May;32(5):683-7.
23- Zelinka T, Eisenhofer G, Pacak K Pheochromocytoma as a
catecholamine producing tumor: implications for clinical
practice. Stress. 2007 Jun;10(2):195-203
24- Plouin PF, Gimenez-Roqueplo AP. Pheochromocytomas and
secreting paragangliomas. Orphanet J Rare Dis. 2006 Dec
8;1:49
25- Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The
diagnosis and management of malignant phaeochromocytoma S.O. Serin, ark.
16
and paraganglioma. Endocr Relat Cancer. 2007 Sep;14(3):569-
85
26- Tajiri S. Vanillylmandelic acid (VMA) and homovanillic acid
(HVA)] Nippon Rinsho. 2005 Aug;63 Suppl
27- Andjelković Z, Tavcar I. Personal experience in diagnosis and
localization of pheochromocytoma Srp Arh Celok Lek. 2002
Jul;130 Suppl 2:14-9
28- Zapanti E, Ilias I. Pheochromocytoma: physiopathologic
implications and diagnostic evaluation Ann N Y Acad Sci.
2006 Nov;1088:346-60
29- Karel Pacak, MD, PhD, Recent Advances in Genetics,
Diagnosis, Localization, and Treatment of Pheochromocytoma
Annals of Internal Medicine 2001Feb; 134 -4

Thank you for copying data from http://www.arastirmax.com